IL-1β, IL-10 and TNF-α polymorphisms may affect systemic lupus erythematosus risk and phenotype

Area of Science:

• Immunogenetics
• Rheumatology
• Molecular Biology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
• Interleukin-1 beta (IL-1β), Interleukin-10 (IL-10), and Tumor Necrosis Factor-alpha (TNF-α) genes play crucial roles in SLE pathogenesis.
• Genetic polymorphisms in these cytokine genes are investigated for their association with SLE.

Purpose of the Study:

• To investigate the impact of specific polymorphisms in IL-1β, IL-10, and TNF-α genes on the risk and phenotype of SLE.
• To analyze the association between IL-1β (-511, +3953), IL-10 (-592, -1082), and TNF-α (-308, -238, +489) gene polymorphisms and SLE susceptibility.
• To explore the relationship between these genetic variations and clinical manifestations, as well as serum cytokine levels in SLE patients.

Main Methods:

• Genotyping of SLE patients and healthy controls using real-time PCR.
• Quantification of serum cytokine levels (IL-1β, IL-10, TNF-α) via enzyme-linked immunosorbent assay (ELISA).
• Statistical analysis to determine the association between polymorphisms, SLE risk, phenotype, and cytokine levels.

Main Results:

• Polymorphisms in TNF-α (-308), IL-10 (-592, -1082), IL-1β (-511, +3953) were found to significantly affect SLE risk.
• Specific genotypes of TNF-α (+489, -238), IL-10 (-1082), and IL-1β (+3953) were associated with distinct SLE phenotypes.
• A correlation was established between certain genotypes and serum concentrations of TNF-α, IL-1β, and IL-10.

Conclusions:

• IL-1β (-511, +3953), IL-10 (-592, -1082), and TNF-α (-308) polymorphisms are implicated in influencing both the risk and phenotype of SLE.
• These genetic variations may serve as potential biomarkers for SLE susceptibility and clinical course.
• The study highlights the intricate role of cytokine gene polymorphisms in the immunopathogenesis of SLE.